Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

This approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in people with diabetes. About one in three adults with diabetes have kidney ...

Bayer's big investment in time and money on the development of finerenone for chronic kidney disease (CKD ... other countries for patients with CKD and type 2 diabetes. Bayer meanwhile is also ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Glomerular hyperfiltration may increase CVD risks, including myocardial infarction and heart failure, for patients with type ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney ...